Uluru Inc (ULUR) 0.2800 $ULUR
ULURU Inc. To Raise $1,550,000 In Private Placement
PR Newswire - Fri Sep 11, 7:00AM CDT
ULURU Inc. (OTCQB: ULUR), a specialty pharmaceutical company focused on the development of a portfolio of wound management and oral care products, today announced the signing of a definitive agreement to sell an aggregate of 4,079,539 shares of its common stock at a price per share of $0.38 to a group of European investors, which is expected to result in gross proceeds of $1,550,225. Under the terms of the agreement, the Company is obligated to file a registration statement registering the re-sale of the purchased shares, and the transaction will close promptly following the effectiveness of the registration statement. Such registration statement is required to be filed with the Securities and Exchange Commission promptly and the Company will use its best efforts to have it declared effective at the earliest possible date. The net proceeds of the private placement after expenses is estimated to be approximately $1,350,000.
ULURU Inc. Reports Second Quarter 2015 Financial Results
PR Newswire - Mon Aug 17, 7:00AM CDT
ULURU Inc. (OTCQB: ULUR) today announced its financial results for the second quarter ended June 30, 2015 and provided a review of its business activities.
ULURU Inc. Announces Conference Call To Discuss Financial Results For The Second Quarter 2015
PR Newswire - Wed Aug 05, 4:37PM CDT
ULURU Inc. (OTCQB: ULUR) today announced that it has scheduled a conference call to discuss the second quarter ending June 30, 2015 financial results and to provide a general business update on August 17, 2015 at 9:00 a.m. Eastern Time.
ULURU Inc. Announces The Schedule For The 2015 Annual Meeting Of Stockholders And The Appointment Of Bradley J. Sacks To The Board Of Directors
PR Newswire - Tue Jul 28, 7:30AM CDT
ULURU Inc. (OTCQB: ULUR) announced today the schedule for the 2015 Annual Meeting of Stockholders and the appointment of Bradley J. Sacks to the Company's Board of Directors.
ULURU Inc. Announces Interim Pharmacoeconomic Data
PR Newswire - Tue Jun 09, 7:00AM CDT
ULURU Inc. (OTCQB: ULUR) announced today interim results of a pharmacoeconomic evaluation being conducted in Europe.
Uluru's (ULUR) CEO Kerry Gray on Q1 2015 Results -- Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Mon May 18, 10:17AM CDT
ULURU Inc. Reports First Quarter 2015 Financial Results
PR Newswire - Mon May 18, 7:00AM CDT
ULURU Inc. (OTCQB: ULUR) today announced its financial results for the first quarter ended March 31, 2015 and provided a review of its operating activities.
ULURU Inc. Announces The Acquisition Of Altrazeal Trading GmbH
PR Newswire - Thu May 14, 8:35AM CDT
ULURU Inc. (OTCQB: ULUR) announced it will be acquiring the 75% ownership of Altrazeal Trading GmbH not currently owned by the Company. The company was granted the option pursuant to a Shareholders Agreement dated January 11, 2012, to acquire the remaining ownership for a predetermined valuation. Altrazeal Trading GmbH was established to commercialize Altrazeal, our proprietary wound care product, in Europe, the Middle East, and Australia/New Zealand.
ULURU Inc. Announces Conference Call To Discuss Financial Results For The First Quarter 2015
PR Newswire - Tue May 12, 4:55PM CDT
ULURU Inc. (OTCQB: ULUR) today announced that it has scheduled a conference call to discuss the first quarter ending March 31, 2015 financial results and to provide a general business update on May 18, 2015 at 9:00 a.m. Eastern Time.
ULURU Inc. Announces the Settlement of Outstanding Litigation
PR Newswire - Mon Apr 20, 7:30AM CDT
ULURU Inc. (OTCQB: ULUR) announced today that they have entered a settlement agreement with Inter-Mountain Capital Corporation ("Inter-Mountain"
to resolve the outstanding litigation associated with a warrant exercise.
ULURU's (ULUR) CEO Kerry Gray on Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Wed Apr 01, 10:20AM CDT
ULURU Inc. Reports Financial Results For Fourth Quarter And Year Ending December 31, 2014
PR Newswire - Wed Apr 01, 7:30AM CDT
ULURU Inc. (OTCQB: ULUR) today announced its financial results for the fourth quarter and year ended December 31, 2014 and provided a review of its operating activities.
ULURU Inc. Announces Conference Call To Discuss Financial Results For The Fourth Quarter And Year Ending December 31, 2014
PR Newswire - Wed Mar 25, 9:19AM CDT
ULURU Inc. (OTCQB: ULUR) today announced that it has scheduled a conference call to discuss the fourth quarter and year ending December 31, 2014 financial results and to provide a general business update on April 1, 2015 at 9:00 a.m. Eastern Time.
ULURU Inc. Announces The Extension And Expansion Of The Option Granted To OraDisc GmbH
PR Newswire - Wed Mar 11, 11:59AM CDT
ULURU Inc. (OTCQB: ULUR) announced today the extension to December 31, 2015 of the option granted to OraDisc GmbH for the use of our OraDisc(TM) technology for drug delivery. The therapeutic categories covered by the agreement have been expanded to include anti-psychotics, neurologics and erectile dysfunction.
ULURU Inc. Provides Business Update
PR Newswire - Mon Jan 12, 8:36AM CST
ULURU Inc. (OTCQB: ULUR) today provided an update on recent developments.
ULURU Inc. (ULUR) CEO Kerry Gray on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Mon Nov 17, 12:27PM CST
ULURU Inc. Reports Third Quarter 2014 Financial Results
PR Newswire - Mon Nov 17, 7:00AM CST
ULURU Inc. (OTCQB: ULUR) today announced its financial results for the third quarter ended September 30, 2014 and provided a review of its operating activities. During the past 90 days significant progress has been made, including:
ULURU Inc. Announces Conference Call To Discuss Financial Results For The Third Quarter Ended September 30, 2014 And To Provide A Business Update
PR Newswire - Mon Nov 10, 2:43PM CST
ULURU Inc. (OTCQB: ULUR) today announced that it has scheduled a conference call to discuss the third quarter ending September 30, 2014 financial results and to provide a business update on November 17, 2014 at 9:00 a.m. Eastern Time.
ULURU Inc. Announces The Expansion Of The International Altrazeal Marketing Network
PR Newswire - Tue Sep 30, 7:00AM CDT
ULURU Inc. (OTCQB: ULUR), today announced the expansion of the Altrazeal® international marketing network. An agreement has been signed granting the exclusive marketing and distribution rights for Altrazeal® in Germany.
ULURU Inc. To Raise $1,550,000 In Private Placement
PR Newswire - Fri Sep 11, 7:00AM CDT
ULURU Inc. (OTCQB: ULUR), a specialty pharmaceutical company focused on the development of a portfolio of wound management and oral care products, today announced the signing of a definitive agreement to sell an aggregate of 4,079,539 shares of its common stock at a price per share of $0.38 to a group of European investors, which is expected to result in gross proceeds of $1,550,225. Under the terms of the agreement, the Company is obligated to file a registration statement registering the re-sale of the purchased shares, and the transaction will close promptly following the effectiveness of the registration statement. Such registration statement is required to be filed with the Securities and Exchange Commission promptly and the Company will use its best efforts to have it declared effective at the earliest possible date. The net proceeds of the private placement after expenses is estimated to be approximately $1,350,000.
ULURU Inc. Reports Second Quarter 2015 Financial Results
PR Newswire - Mon Aug 17, 7:00AM CDT
ULURU Inc. (OTCQB: ULUR) today announced its financial results for the second quarter ended June 30, 2015 and provided a review of its business activities.
ULURU Inc. Announces Conference Call To Discuss Financial Results For The Second Quarter 2015
PR Newswire - Wed Aug 05, 4:37PM CDT
ULURU Inc. (OTCQB: ULUR) today announced that it has scheduled a conference call to discuss the second quarter ending June 30, 2015 financial results and to provide a general business update on August 17, 2015 at 9:00 a.m. Eastern Time.
ULURU Inc. Announces The Schedule For The 2015 Annual Meeting Of Stockholders And The Appointment Of Bradley J. Sacks To The Board Of Directors
PR Newswire - Tue Jul 28, 7:30AM CDT
ULURU Inc. (OTCQB: ULUR) announced today the schedule for the 2015 Annual Meeting of Stockholders and the appointment of Bradley J. Sacks to the Company's Board of Directors.
ULURU Inc. Announces Interim Pharmacoeconomic Data
PR Newswire - Tue Jun 09, 7:00AM CDT
ULURU Inc. (OTCQB: ULUR) announced today interim results of a pharmacoeconomic evaluation being conducted in Europe.
Uluru's (ULUR) CEO Kerry Gray on Q1 2015 Results -- Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Mon May 18, 10:17AM CDT
ULURU Inc. Reports First Quarter 2015 Financial Results
PR Newswire - Mon May 18, 7:00AM CDT
ULURU Inc. (OTCQB: ULUR) today announced its financial results for the first quarter ended March 31, 2015 and provided a review of its operating activities.
ULURU Inc. Announces The Acquisition Of Altrazeal Trading GmbH
PR Newswire - Thu May 14, 8:35AM CDT
ULURU Inc. (OTCQB: ULUR) announced it will be acquiring the 75% ownership of Altrazeal Trading GmbH not currently owned by the Company. The company was granted the option pursuant to a Shareholders Agreement dated January 11, 2012, to acquire the remaining ownership for a predetermined valuation. Altrazeal Trading GmbH was established to commercialize Altrazeal, our proprietary wound care product, in Europe, the Middle East, and Australia/New Zealand.
ULURU Inc. Announces Conference Call To Discuss Financial Results For The First Quarter 2015
PR Newswire - Tue May 12, 4:55PM CDT
ULURU Inc. (OTCQB: ULUR) today announced that it has scheduled a conference call to discuss the first quarter ending March 31, 2015 financial results and to provide a general business update on May 18, 2015 at 9:00 a.m. Eastern Time.
ULURU Inc. Announces the Settlement of Outstanding Litigation
PR Newswire - Mon Apr 20, 7:30AM CDT
ULURU Inc. (OTCQB: ULUR) announced today that they have entered a settlement agreement with Inter-Mountain Capital Corporation ("Inter-Mountain"
to resolve the outstanding litigation associated with a warrant exercise. ULURU's (ULUR) CEO Kerry Gray on Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Wed Apr 01, 10:20AM CDT
ULURU Inc. Reports Financial Results For Fourth Quarter And Year Ending December 31, 2014
PR Newswire - Wed Apr 01, 7:30AM CDT
ULURU Inc. (OTCQB: ULUR) today announced its financial results for the fourth quarter and year ended December 31, 2014 and provided a review of its operating activities.
ULURU Inc. Announces Conference Call To Discuss Financial Results For The Fourth Quarter And Year Ending December 31, 2014
PR Newswire - Wed Mar 25, 9:19AM CDT
ULURU Inc. (OTCQB: ULUR) today announced that it has scheduled a conference call to discuss the fourth quarter and year ending December 31, 2014 financial results and to provide a general business update on April 1, 2015 at 9:00 a.m. Eastern Time.
ULURU Inc. Announces The Extension And Expansion Of The Option Granted To OraDisc GmbH
PR Newswire - Wed Mar 11, 11:59AM CDT
ULURU Inc. (OTCQB: ULUR) announced today the extension to December 31, 2015 of the option granted to OraDisc GmbH for the use of our OraDisc(TM) technology for drug delivery. The therapeutic categories covered by the agreement have been expanded to include anti-psychotics, neurologics and erectile dysfunction.
ULURU Inc. Provides Business Update
PR Newswire - Mon Jan 12, 8:36AM CST
ULURU Inc. (OTCQB: ULUR) today provided an update on recent developments.
ULURU Inc. (ULUR) CEO Kerry Gray on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Mon Nov 17, 12:27PM CST
ULURU Inc. Reports Third Quarter 2014 Financial Results
PR Newswire - Mon Nov 17, 7:00AM CST
ULURU Inc. (OTCQB: ULUR) today announced its financial results for the third quarter ended September 30, 2014 and provided a review of its operating activities. During the past 90 days significant progress has been made, including:
ULURU Inc. Announces Conference Call To Discuss Financial Results For The Third Quarter Ended September 30, 2014 And To Provide A Business Update
PR Newswire - Mon Nov 10, 2:43PM CST
ULURU Inc. (OTCQB: ULUR) today announced that it has scheduled a conference call to discuss the third quarter ending September 30, 2014 financial results and to provide a business update on November 17, 2014 at 9:00 a.m. Eastern Time.
ULURU Inc. Announces The Expansion Of The International Altrazeal Marketing Network
PR Newswire - Tue Sep 30, 7:00AM CDT
ULURU Inc. (OTCQB: ULUR), today announced the expansion of the Altrazeal® international marketing network. An agreement has been signed granting the exclusive marketing and distribution rights for Altrazeal® in Germany.
